Insider Monkey

It’s a well-established truth that insiders often benefit from their own trades. In 2009, over 59,000 insiders reported their transactions to the SEC, while the previous year saw more than 65,000 filings. Simply copying all these insiders isn’t likely to be effective. However, focusing on the top-performing insiders with proven success can be much more rewarding. Insider Monkey employs a mixed assessment approach that analyzes insider trades and other market irregularities to filter out the most promising insiders to follow. Additionally, Insider Monkey offers well-researched, evidence-based articles to help individual investors understand the complexities of investing.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#21433

United States

#6120

Finance/Investing

#75

Traffic sources

Monthly visitors

Articles

UBS Lifts Five Below (FIVE)’s PT to $160 from $110, Keeps Buy Rating

1 day ago | insidermonkey.com | Hamna Asim

On June 5, UBS increased the target price for Five Below, Inc. (NASDAQ:FIVE) to $160 from $110, while reiterating a Buy recommendation on the stock. The analysts largely attributed their decision to FIVE’s robust recent performance. The stock has demonstrated promising momentum with a year-to-date increase of 15.51%. The analysts mentioned many determinants of Five Below’s solid performance and stressed that the company is capable of sustaining the momentum.
Eli Lilly (LLY)’s Target Price Slashed to $960 by TD Cowen, Reiterates Buy Rating

1 day ago | insidermonkey.com | Hamna Asim

On June 5, TD Cowen analysts trimmed the price target for Eli Lilly and Company (NYSE:LLY) from $1,050 to $960, while reiterating a Buy rating on the stock. This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT trial. TD Cowen’s analysis demonstrates that LLY’s tirzepatide needs to match a MACE hazard ratio of 0.9 or better to statistically outperform dulaglutide.
TD Cowen Affirms Buy Rating on American Tower (AMT) with $241 PT, Citing Solid Demand

1 day ago | insidermonkey.com | Hamna Asim

On June 5, TD Cowen analysts maintained a Buy recommendation on American Tower Corporation (NYSE:AMT) with a target price of $241, far surpassing present trading levels. The firm reiterated its confidence in AMT’s growth trajectory, noting robust enterprise demand despite ongoing macroeconomic headwinds. TD Cowen analysts observed that initial talks on tower densification have started, and demand for GenAI inference fiber might arise sooner than expected.
TD Cowen Affirms Hold Rating on McDonald’s (MCD) with a $305 Price Target

1 day ago | insidermonkey.com | Hamna Asim

On June 5, TD Cowen maintained a Hold rating on McDonald’s Corporation (NYSE:MCD) with a $305 price target. This decision came after insights from experts from the quick service industry, which resulted in forecasts of a 2.8% boost in US same-store sales for Q2 2025. The analysts expect MCD shares to range from $305 to $320, noting the robust dividend record of consistently increasing dividends for 49 years.
Bernstein Maintains a Market Perform Rating on Etsy (ETSY), Sets Price Target at $45

1 day ago | insidermonkey.com | Hamna Asim

Bernstein SocGen Group maintained a Market Perform rating on Etsy, Inc. (NASDAQ:ETSY) with a price target of $45 on June 5. The analysts observed that growing investor confidence and potential short covering led Etsy shares to climb 32% since last month. Bernstein analysts noted that the upward momentum in Etsy, Inc. (NASDAQ:ETSY) stock is due to stronger alternative data indicating a slowdown in the annual decline of Gross Merchandise Sales in May.
The Southern Company (SO) Upgraded at Jefferies on Promising Growth Prospects

1 day ago | insidermonkey.com | Hamna Asim

Jefferies upgraded The Southern Company (NYSE:SO) to Buy from Hold on solid growth outlook, while adjusting the price target from $102 to $100 on June 5. According to the analysts, Southern Co.’s possible success in future requests for proposals (RFPs) could lead to considerable rate base growth, outperforming industry peers. A Southern Co. subsidiary, Georgia Power, is projected to obtain over 70% of an 8.5 gigawatt project, corresponding to nearly $12.9 billion in extra capital spending.
HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold

1 day ago | insidermonkey.com | Hamna Asim

On June 5, HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. HSBC’s updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid.
JPMorgan Trims the PT for Warner Music Group (WMG) to $32

1 day ago | insidermonkey.com | Hamna Asim

JPMorgan analysts trimmed the price target for Warner Music Group Corp. (NASDAQ:WMG) to $32 from $38 on June 5, while keeping an Overweight rating on the stock. The price target was adjusted after WMG’s recent performance, with the shares dropping 7% after its fiscal Q2 results were released on May 8. As Warner Music posted its Q2 earnings miss, it led to reduced consensus forecasts, which in turn dragged on the company’s performance.
Jefferies Downgrades Chewy (CHWY) to Hold, Flags Valuation Concerns

1 day ago | insidermonkey.com | Hamna Asim

On June 5, Jefferies downgraded Chewy, Inc. (NYSE:CHWY) to Hold from Buy, highlighting concerns over valuation. Despite that, the price target was raised to $43 from $41, and the analysts observed that Chewy’s stock has surged 41% year-to-date. The analysts had reservations about Chewy’s capacity to outperform Street estimates in the upcoming Q1 results, to be released on June 11. Jefferies observed that Chewy, Inc.
JPMorgan Slashes FedEx Corporation (FDX) PT to $260 Over Demand Concerns

1 day ago | insidermonkey.com | Hamna Asim

On June 5, JPMorgan trimmed the price target for FedEx Corporation (NYSE:FDX) from $280 to $260 while reiterating an Overweight rating on the stock. Analysts have adjusted their outlook based on weak demand trends and the current tariff climate as the earnings date for FDX approaches. FedEx’s earnings call is scheduled for June 24, where many significant topics will be discussed. These include capacity utilization at FedEx, a recent collaboration with Amazon.com, Inc.